Table Graph
      published meta-analysis   sensitivity analysis   studies

chloroquine and derivatives in COVID-19 prophylaxis (excluding children) - Summary of results

OutcomeTE95% CInkI2ROBPub. bias symptomatic Covid-19detailed resultsSeet (HCQ), 2021 0.91 [0.57; 1.47] 0.91[0.57; 1.47]Seet (HCQ), 202110%645NAnot evaluable infection (PCR positive symptomatic or not)detailed resultsSeet (HCQ), 2021 0.41 [0.32; 0.53] 0.41[0.32; 0.53]Seet (HCQ), 202110%1,051NAnot evaluable0.22.01.0relative treatment effectwww.metaEvidence.org2024-05-11 08:07 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 89 - treatments: 508,656,657,832 - roots T: 290

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons